TAF9B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.845000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.452200E-01
Normal-vs-Stage2
2.881800E-01
Normal-vs-Stage3
1.630030E-01
Normal-vs-Stage4
3.841000E-01
Stage1-vs-Stage2
2.191400E-01
Stage1-vs-Stage3
1.878620E-01
Stage1-vs-Stage4
3.544200E-01
Stage2-vs-Stage3
5.147000E-01
Stage2-vs-Stage4
8.521800E-01
Stage3-vs-Stage4
4.043200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.323400E-01
Normal-vs-AfricanAmerican
6.403800E-01
Normal-vs-Asian
4.264300E-02
Caucasian-vs-AfricanAmerican
8.755800E-01
Caucasian-vs-Asian
4.896300E-02
AfricanAmerican-vs-Asian
9.863700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.132000E-01
Normal-vs-Female
4.696600E-01
Male-vs-Female
9.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.848200E-01
Normal-vs-Age(41-60Yrs)
8.410600E-01
Normal-vs-Age(61-80Yrs)
3.351000E-01
Normal-vs-Age(81-100Yrs)
3.187900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.246800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.443400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.577200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.478270E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.818680E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.392990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.654400E-02
Normal-vs-Daily Drinker
6.146200E-01
Normal-vs-Weekly Drinker
1.518630E-01
Normal-vs-Occasional Drinker
7.985800E-01
Normal-vs-Social Drinker
8.572200E-01
Non Drinker-vs-Daily Drinker
3.400800E-01
Non Drinker-vs-Weekly Drinker
9.977800E-01
Non Drinker-vs-Occasional Drinker
6.441900E-02
Non Drinker-vs-Social Drinker
1.734990E-01
Daily Drinker-vs-Weekly Drinker
3.941600E-01
Daily Drinker-vs-Occasional Drinker
5.422000E-01
Daily Drinker-vs-Social Drinker
5.896600E-01
Weekly Drinker-vs-Occasional Drinker
1.183960E-01
Weekly Drinker-vs-Social Drinker
2.018800E-01
Occasional Drinker-vs-Social Drinker
9.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.717000E-01
Normal-vs-Grade 2
9.902400E-01
Normal-vs-Grade 3
9.509600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.432200E-02
Grade 1-vs-Grade 3
7.668200E-02
Grade 1-vs-Grade 4
5.717000E-01
Grade 2-vs-Grade 3
4.756400E-01
Grade 2-vs-Grade 4
9.902400E-01
Grade 3-vs-Grade 4
9.509600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.362600E-01
Normal-vs-NonDiabetic
5.073800E-01
Diabetic-vs-NonDiabetic
3.758200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.484580E-01
Normal-vs-NoPancreatitis
4.440800E-01
Pancreatitis-vs-NoPancreatitis
3.824800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.271000E-01
Normal-vs-N1
3.251000E-01
N0-vs-N1
3.969800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.080800E-01
Normal-vs-TP53-NonMutant
9.541400E-01
TP53-Mutant-vs-TP53-NonMutant
1.414110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
